drugset / Trial / NCT01885910

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

NCT01885910

Phase 4 Completed 32 enrolled Derm Research, PLLC WFH MEDICAL, LLC · collab
NaSingle-groupOpen-labelTreatment

Summary

This pilot study will explore if continuation of treatment of treatment with Aczone 5% gel following combination treatment with with doxycycline and Aczone 5% gel can maintain therapeutic response.

Timeline

Start
2013-07
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapsone Small molecule 5 % Topical
Background Doxycycline Small molecule 100 mg Oral

Indications